Newsroom

Hyperthermia System for Cancer Treatment Installed at Lankenau Medical Center

Wednesday, November 12, 2008

First hospital in Philadelphia region to acquire new technology

(Wynnewood, PA, November 12, 2008)—The Lankenau Medical Center Department of Radiation Oncology has become the first hospital in the Philadelphia region and the 17th nationwide to acquire the BSD hyperthermia system for use in the treatment of cancer. The addition of the system significantly adds to the multidisciplinary arsenal of cancer treatment options Lankenau provides to the Philadelphia and Main Line community.

The BSD Hyperthermia unit delivers precision-focused heat energy to tumors in the body.  It is used in combination with radiation therapy and in some instances chemotherapy to enhance treatment effects by making cancer cells more sensitive to radiation. Hyperthermia treatment is typically delivered twice per week prior to radiation treatments.

In Phase III clinical trials where hyperthermia therapy was combined with radiation therapy, hyperthermia improved complete response for recurrent breast, head and neck, melanoma, and other cancers from 23 to 68 percent.

Hyperthermia combined with radiation therapy has also shown improved control rates for patients with advanced cervical cancer.

“We are confident that the addition of hyperthermia to our treatment options will provide significant potential benefits to many of our patients,” says Dr. Marisa Weiss, Director of Breast Radiation Oncology and Breast Health Outreach at Lankenau Medical Center and founder and president of Breast Cancer.org.

“Main Line Health System treats approximately 3000 cancer patients annually with remarkable results, improving overall survival and quality of life,” said Dr. Albert Denittis, Chief of Radiation Oncology. “We are pleased to be the first hospital in the region to offer this treatment modality to our patients.”

“The Lankenau Radiation Oncology Department has been on the cutting-edge of technology in acquiring weapons to further expand our services in the fight against cancer and hyperthermia furthers this commitment to our patients,” says Gary Antonelli, Radiation Oncology Administrator.

Contact
Frieda Schmidt
Media Relations
Main Line Health
484-337-8298
schmidtf@mlhs.org

Connect with

New Appointments
1.866.CALL.MLH


STAY CONNECTED

Copyright 2011 Main Line Health

Printed from: www.mainlinehealth.org/wtn/Page.asp?PageID=WTN000678

The information provided in this Web site is for informational purposes only. It is not a substitute for medical advice. All medical information presented should be discussed with your healthcare professional. See additional Terms of Use at www.mainlinehealth.org/terms. For more information, call 1.866.CALL.MLH.